Loading…

Combined PCI and minimally invasive heart valve surgery for high-risk patients

Opinion statement Combined coronary artery valvular heart disease is a major cause of morbidity and mortality in the adult patient population. The standard treatment for such disease has been open heart surgery in which coronary artery bypass grafting (CABG) is performed concurrently with valve surg...

Full description

Saved in:
Bibliographic Details
Published in:Current treatment options in cardiovascular medicine 2009-12, Vol.11 (6), p.492-498
Main Authors: Umakanthan, Ramanan, Leacche, Marzia, Petracek, Michael R., Zhao, David X., Byrne, John G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333
cites cdi_FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333
container_end_page 498
container_issue 6
container_start_page 492
container_title Current treatment options in cardiovascular medicine
container_volume 11
creator Umakanthan, Ramanan
Leacche, Marzia
Petracek, Michael R.
Zhao, David X.
Byrne, John G.
description Opinion statement Combined coronary artery valvular heart disease is a major cause of morbidity and mortality in the adult patient population. The standard treatment for such disease has been open heart surgery in which coronary artery bypass grafting (CABG) is performed concurrently with valve surgery using a median sternotomy and cardiopulmonary bypass. With the increasing complexity of patients referred to surgery, some patients may prove to be poor surgical candidates for combined valve and CABG surgery. In certain selected patients who fall into this category, valve surgery and percutaneous coronary intervention (PCI) have been considered a feasible alternative. Conventionally, valve surgery is performed in the cardiac surgical operating room, whereas PCI is carried out in the cardiac catheterization laboratory. Separation of these two procedural suites has presented a logistic limitation because it impedes the concomitant performance of both procedures in one setting. Hence, PCI and valve surgery usually have been performed as a “two-stage” procedure in two different operative suites, with the procedures being separated by hours, days, or weeks. Technologic advancements have made possible the construction of a “hybrid” procedural suite that combines the facilities of a cardiac surgical operating room with those of a cardiac catheterization laboratory. This design has enabled the concept of “one-stage” or “one-stop” PCI and valve surgery, allowing both procedures to be performed in a hybrid suite in one setting, separated by minutes. The advantages of such a method could prove to be multifold by enabling a less invasive surgical approach and improving logistics, patient satisfaction, and outcomes in selected patients.
doi_str_mv 10.1007/s11936-009-0052-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733562273</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2919734346</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333</originalsourceid><addsrcrecordid>eNp1kF1LwzAUhoMobk5_gDcS8MKrak7SpsmlFD8GQ73Q65C26ZbZj5m0g_17MzoYCF6EnJDnvOfwIHQN5B4ISR88gGQ8IkSGk9CInqApJCyOGAh5GmoiaSRiHk_QhfdrQmjChDhHE5CSESnSKXrLuia3rSnxRzbHui1xY1vb6LreYdtutbdbg1dGux5vdR1qP7ilcTtcdQ6v7HIVOeu_8Ub31rS9v0Rnla69uTrcM_T1_PSZvUaL95d59riICio4jVgCUpRlIgqdl9RURsoyAR4TWZKYQ3iG1YEXAFSK3BBS6VQISYimkgNjbIbuxtyN634G43vVWF-Yutat6QavUsYSTmm6J2__kOtucG1YTlEJMmUxi3mgYKQK13nvTKU2LlhwOwVE7V2r0bUKrtXetaKh5-aQPOSNKY8dB7kBoCPgw1cbrB1H_5_6C2zAh0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2919734346</pqid></control><display><type>article</type><title>Combined PCI and minimally invasive heart valve surgery for high-risk patients</title><source>Springer Nature</source><creator>Umakanthan, Ramanan ; Leacche, Marzia ; Petracek, Michael R. ; Zhao, David X. ; Byrne, John G.</creator><creatorcontrib>Umakanthan, Ramanan ; Leacche, Marzia ; Petracek, Michael R. ; Zhao, David X. ; Byrne, John G.</creatorcontrib><description>Opinion statement Combined coronary artery valvular heart disease is a major cause of morbidity and mortality in the adult patient population. The standard treatment for such disease has been open heart surgery in which coronary artery bypass grafting (CABG) is performed concurrently with valve surgery using a median sternotomy and cardiopulmonary bypass. With the increasing complexity of patients referred to surgery, some patients may prove to be poor surgical candidates for combined valve and CABG surgery. In certain selected patients who fall into this category, valve surgery and percutaneous coronary intervention (PCI) have been considered a feasible alternative. Conventionally, valve surgery is performed in the cardiac surgical operating room, whereas PCI is carried out in the cardiac catheterization laboratory. Separation of these two procedural suites has presented a logistic limitation because it impedes the concomitant performance of both procedures in one setting. Hence, PCI and valve surgery usually have been performed as a “two-stage” procedure in two different operative suites, with the procedures being separated by hours, days, or weeks. Technologic advancements have made possible the construction of a “hybrid” procedural suite that combines the facilities of a cardiac surgical operating room with those of a cardiac catheterization laboratory. This design has enabled the concept of “one-stage” or “one-stop” PCI and valve surgery, allowing both procedures to be performed in a hybrid suite in one setting, separated by minutes. The advantages of such a method could prove to be multifold by enabling a less invasive surgical approach and improving logistics, patient satisfaction, and outcomes in selected patients.</description><identifier>ISSN: 1092-8464</identifier><identifier>EISSN: 1534-3189</identifier><identifier>DOI: 10.1007/s11936-009-0052-2</identifier><identifier>PMID: 19930987</identifier><language>eng</language><publisher>New York: Current Science Inc</publisher><subject>Cardiac catheterization ; Cardiology ; Coronary vessels ; Intubation ; Medicine ; Medicine &amp; Public Health ; Patient satisfaction ; Surgery</subject><ispartof>Current treatment options in cardiovascular medicine, 2009-12, Vol.11 (6), p.492-498</ispartof><rights>Current Medicine Group, LLC 2009</rights><rights>Current Medicine Group, LLC 2009.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333</citedby><cites>FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19930987$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Umakanthan, Ramanan</creatorcontrib><creatorcontrib>Leacche, Marzia</creatorcontrib><creatorcontrib>Petracek, Michael R.</creatorcontrib><creatorcontrib>Zhao, David X.</creatorcontrib><creatorcontrib>Byrne, John G.</creatorcontrib><title>Combined PCI and minimally invasive heart valve surgery for high-risk patients</title><title>Current treatment options in cardiovascular medicine</title><addtitle>Curr Treat Options Cardio Med</addtitle><addtitle>Curr Treat Options Cardiovasc Med</addtitle><description>Opinion statement Combined coronary artery valvular heart disease is a major cause of morbidity and mortality in the adult patient population. The standard treatment for such disease has been open heart surgery in which coronary artery bypass grafting (CABG) is performed concurrently with valve surgery using a median sternotomy and cardiopulmonary bypass. With the increasing complexity of patients referred to surgery, some patients may prove to be poor surgical candidates for combined valve and CABG surgery. In certain selected patients who fall into this category, valve surgery and percutaneous coronary intervention (PCI) have been considered a feasible alternative. Conventionally, valve surgery is performed in the cardiac surgical operating room, whereas PCI is carried out in the cardiac catheterization laboratory. Separation of these two procedural suites has presented a logistic limitation because it impedes the concomitant performance of both procedures in one setting. Hence, PCI and valve surgery usually have been performed as a “two-stage” procedure in two different operative suites, with the procedures being separated by hours, days, or weeks. Technologic advancements have made possible the construction of a “hybrid” procedural suite that combines the facilities of a cardiac surgical operating room with those of a cardiac catheterization laboratory. This design has enabled the concept of “one-stage” or “one-stop” PCI and valve surgery, allowing both procedures to be performed in a hybrid suite in one setting, separated by minutes. The advantages of such a method could prove to be multifold by enabling a less invasive surgical approach and improving logistics, patient satisfaction, and outcomes in selected patients.</description><subject>Cardiac catheterization</subject><subject>Cardiology</subject><subject>Coronary vessels</subject><subject>Intubation</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Patient satisfaction</subject><subject>Surgery</subject><issn>1092-8464</issn><issn>1534-3189</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp1kF1LwzAUhoMobk5_gDcS8MKrak7SpsmlFD8GQ73Q65C26ZbZj5m0g_17MzoYCF6EnJDnvOfwIHQN5B4ISR88gGQ8IkSGk9CInqApJCyOGAh5GmoiaSRiHk_QhfdrQmjChDhHE5CSESnSKXrLuia3rSnxRzbHui1xY1vb6LreYdtutbdbg1dGux5vdR1qP7ilcTtcdQ6v7HIVOeu_8Ub31rS9v0Rnla69uTrcM_T1_PSZvUaL95d59riICio4jVgCUpRlIgqdl9RURsoyAR4TWZKYQ3iG1YEXAFSK3BBS6VQISYimkgNjbIbuxtyN634G43vVWF-Yutat6QavUsYSTmm6J2__kOtucG1YTlEJMmUxi3mgYKQK13nvTKU2LlhwOwVE7V2r0bUKrtXetaKh5-aQPOSNKY8dB7kBoCPgw1cbrB1H_5_6C2zAh0A</recordid><startdate>200912</startdate><enddate>200912</enddate><creator>Umakanthan, Ramanan</creator><creator>Leacche, Marzia</creator><creator>Petracek, Michael R.</creator><creator>Zhao, David X.</creator><creator>Byrne, John G.</creator><general>Current Science Inc</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200912</creationdate><title>Combined PCI and minimally invasive heart valve surgery for high-risk patients</title><author>Umakanthan, Ramanan ; Leacche, Marzia ; Petracek, Michael R. ; Zhao, David X. ; Byrne, John G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Cardiac catheterization</topic><topic>Cardiology</topic><topic>Coronary vessels</topic><topic>Intubation</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Patient satisfaction</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Umakanthan, Ramanan</creatorcontrib><creatorcontrib>Leacche, Marzia</creatorcontrib><creatorcontrib>Petracek, Michael R.</creatorcontrib><creatorcontrib>Zhao, David X.</creatorcontrib><creatorcontrib>Byrne, John G.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Current treatment options in cardiovascular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Umakanthan, Ramanan</au><au>Leacche, Marzia</au><au>Petracek, Michael R.</au><au>Zhao, David X.</au><au>Byrne, John G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined PCI and minimally invasive heart valve surgery for high-risk patients</atitle><jtitle>Current treatment options in cardiovascular medicine</jtitle><stitle>Curr Treat Options Cardio Med</stitle><addtitle>Curr Treat Options Cardiovasc Med</addtitle><date>2009-12</date><risdate>2009</risdate><volume>11</volume><issue>6</issue><spage>492</spage><epage>498</epage><pages>492-498</pages><issn>1092-8464</issn><eissn>1534-3189</eissn><abstract>Opinion statement Combined coronary artery valvular heart disease is a major cause of morbidity and mortality in the adult patient population. The standard treatment for such disease has been open heart surgery in which coronary artery bypass grafting (CABG) is performed concurrently with valve surgery using a median sternotomy and cardiopulmonary bypass. With the increasing complexity of patients referred to surgery, some patients may prove to be poor surgical candidates for combined valve and CABG surgery. In certain selected patients who fall into this category, valve surgery and percutaneous coronary intervention (PCI) have been considered a feasible alternative. Conventionally, valve surgery is performed in the cardiac surgical operating room, whereas PCI is carried out in the cardiac catheterization laboratory. Separation of these two procedural suites has presented a logistic limitation because it impedes the concomitant performance of both procedures in one setting. Hence, PCI and valve surgery usually have been performed as a “two-stage” procedure in two different operative suites, with the procedures being separated by hours, days, or weeks. Technologic advancements have made possible the construction of a “hybrid” procedural suite that combines the facilities of a cardiac surgical operating room with those of a cardiac catheterization laboratory. This design has enabled the concept of “one-stage” or “one-stop” PCI and valve surgery, allowing both procedures to be performed in a hybrid suite in one setting, separated by minutes. The advantages of such a method could prove to be multifold by enabling a less invasive surgical approach and improving logistics, patient satisfaction, and outcomes in selected patients.</abstract><cop>New York</cop><pub>Current Science Inc</pub><pmid>19930987</pmid><doi>10.1007/s11936-009-0052-2</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1092-8464
ispartof Current treatment options in cardiovascular medicine, 2009-12, Vol.11 (6), p.492-498
issn 1092-8464
1534-3189
language eng
recordid cdi_proquest_miscellaneous_733562273
source Springer Nature
subjects Cardiac catheterization
Cardiology
Coronary vessels
Intubation
Medicine
Medicine & Public Health
Patient satisfaction
Surgery
title Combined PCI and minimally invasive heart valve surgery for high-risk patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T05%3A33%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20PCI%20and%20minimally%20invasive%20heart%20valve%20surgery%20for%20high-risk%20patients&rft.jtitle=Current%20treatment%20options%20in%20cardiovascular%20medicine&rft.au=Umakanthan,%20Ramanan&rft.date=2009-12&rft.volume=11&rft.issue=6&rft.spage=492&rft.epage=498&rft.pages=492-498&rft.issn=1092-8464&rft.eissn=1534-3189&rft_id=info:doi/10.1007/s11936-009-0052-2&rft_dat=%3Cproquest_cross%3E2919734346%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2919734346&rft_id=info:pmid/19930987&rfr_iscdi=true